Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Leases (2022 - 2025)

Historic Current Leases for Biodesix (BDSX) over the last 4 years, with Q3 2025 value amounting to $1.4 million.

  • Biodesix's Current Leases rose 12339.74% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 12339.74%. This contributed to the annual value of $719000.0 for FY2024, which is 18531.75% up from last year.
  • Per Biodesix's latest filing, its Current Leases stood at $1.4 million for Q3 2025, which was up 12339.74% from $1.2 million recorded in Q2 2025.
  • Biodesix's 5-year Current Leases high stood at $1.8 million for Q1 2023, and its period low was $252000.0 during Q4 2023.
  • In the last 4 years, Biodesix's Current Leases had a median value of $1.1 million in 2023 and averaged $1.0 million.
  • In the last 5 years, Biodesix's Current Leases tumbled by 8456.3% in 2024 and then surged by 31066.67% in 2025.
  • Over the past 4 years, Biodesix's Current Leases (Quarter) stood at $1.5 million in 2022, then crashed by 83.67% to $252000.0 in 2023, then soared by 185.32% to $719000.0 in 2024, then soared by 93.88% to $1.4 million in 2025.
  • Its Current Leases stands at $1.4 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.1 million for Q1 2025.